A small trial has shown that transplanting immune cells that target Epstein-Barr virus can reduce or reverse the progression of multiple sclerosis.
Coloured transmission electron micrograph showing the early collapse of myelin sheath around a nerve fibreTransplants of immune cells that target the Epstein-Barr virus have shown promise for treating multiple sclerosis in an early trial. Brain scans suggest the progression of the condition was reversed in some participants, but this needs to be confirmed by larger trials.
Multiple sclerosis is caused by someone’s own immune system attacking the myelin coating that helps nerve cells conduct signals, causing a range of symptoms from fatigue to difficulty walking. In most cases, people …App + Web
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: